AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION for AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 17, 2014 | $416,696 | Replaced |
| 3rd Quarter - Amendment | Oct 20, 2014 | $410,421 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus.Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2552/H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014). Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act). Lobby Congress on issues related to telemedicine (H.R. 5380, the Medicare Telehealth Parity Act). Advocate on on use and availability of health care data.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Medicare/Medicaid MMM
Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act).Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 ). Lobby in support of a cap on the amount CMS can decrease payment to physician services in a given year. (related provision included in S.2000/H.R. 4015; SGR Repeal and Medicare Provider Payment Modernization Act of 2014 and H.R. 4302, Protecting Access to Medicare Act). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013, FY 15 President's Budget). Lobby Congress on impact of Health Information Technology. Lobby Congress to stop sequestration cuts to Medicare physician payments (Bipartisan Budget Act of 2013). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Oppose legislation allowing non-physician providers direct access to Medicare patients without a referral (H.R. 5304, Audiology Patient Choice Act of 2014). Advocate on issues related to waste, fraud and abuse in Medicare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Medical/Disease Research/Clinical Labs MED
Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 15 Labor/HHS/Education Appropriations and FY 15 Agriculture Appropriations program request).Support legislation to adjust discretionary spending caps for biomedical research (S. 2658/H.R. 5580, Accelerating Biomedical Research Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Torts TOR
Support legislation to enact medical liability reform (H.R. 1473, the Standard of Care Protection Act). Support inclusion of standard of care provisions similar to H.R. 1473 in S.2000/H.R. 4015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.